Sporos is transforming knowledge into new hope for patients. With deep roots in Texas, connections within Texas Medical Center (TMC) and reach across the industry, the Company identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough medicines. Sporos’ current pipeline is diversified across four entities and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. 

Biotechnology

Sporos Bioventures

Stephen Rubino

Dana Levy

Benjamin Stein

Sharon Shacham

Eric Rowinsky

The Leadership Team at Sporos Bioventures spearheads strategic direction and operational oversight, leveraging their extensive expertise to drive the company's mission of developing innovative medicines. Comprised of the CEO, Consulting Chief Medical Officer, and Co-founder, this team formulates key partnerships and investment strategies while guiding research initiatives to advance clinical candidates in the fight against cancer and immune diseases. Their collaborative efforts ensure that Sporos remains at the forefront of biopharmaceutical innovation, maximizing the impact of its diverse pipeline.

Leadership Team

About

Team members

Other teams at Sporos Bioventures

Consulting and Advisory Team